Most recent update: Sunday, April 29, 2018 - 14:56

You are here

pulmonary embolism

Know the danger signs of CVI and VTE in pregnant patients

A review of the literature on chronic venous insufficiency (CVI) in pregnant women reveals considerable guidance for their treatment. CVI occurs in up to 80% of pregnant women, while around 7 of every 1,000 pregnant mothers face venous thromboembolism (VTE) and pulmonary embolism (PE). Pregnancy causes significant hemodynamic changes within the circulatory system.

Varicose veins associated with DVT incidence

Adults who were diagnosed with varicose veins have a significantly increased risk of incident deep venous thrombosis (DVT), although whether the association between varicose veins and DVT is causal or represents a common set of risk factors requires further research.

Safety and efficacy of shorter, lower dose EKOS therapy for PE

One-year results from the OPTALYSE PE trial confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to show improvements in RV/LV ratio over the long term with a very low all-cause mortality rate of 2%.

Enrolment in KNOCOUT PE Study to protocols for EKOS Therapy

BTG has announced the commencement of the KNOCOUT PE study, which will measure how hospitals and patients are benefitting from a new standard of care in the treatment of pulmonary embolism (PE) utilising EKOS therapy with faster, and even safer protocols, proven effective in the OPTALYSE PE study. The OPTALYSE PE study found PE can be treated effectively with EKOS therapy over a much shorter period and at safer thrombolytic doses far below the previous standard.

Continuous aspiration mechanical thrombectomy feasible for PE

Continuous aspiration mechanical thrombectomy, with the Indigo Mechanical Thrombectomy System (Penumbra), is a feasible and promising intervention for patients with sub-massive pulmonary embolism (PE) and a contraindication to thrombolysis, according a small cases series by researchers from Miami Cardiac & Vascular Institute, Baptist Hospital of Miami, Miami, FL.

Inari completes patient enrolment in the FLARE study for PE

Inari Medical has completed patient enrolment in its Investigational Device Exemption (IDE) FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study, designed to evaluate the safety and effectiveness of the FlowTriever Retrieval/Aspiration System for the treatment of pulmonary embolism.

The FlowTriever System is a catheter-based mechanical thrombectomy device for percutaneous endovascular retrieval and disruption of emboli from the peripheral vasculature without the need for thrombolytics.

Angel Catheter demonstrates a significant reduction fatal PE

Bio2 Medical has announced the results of the Angel Catheter pivotal study, ‘Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients," published in the Journal of Vascular and Interventional Radiology (JVIR).  The outcomes show that the Angel Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE).

YEARS algorithm effectively assesses pulmonary embolism risk

Patients with suspected pulmonary embolism (PE) often undergo computed tomography pulmonary angiography (CTPA) to confirm or exclude the diagnosis. However, CTPA exposes them to radiation, the risk of contrast-induced nephropathy, and increases health care costs. Therefore ways to reduce the use of CTPA in this setting are needed. Findings presented at ESC Congress 2016, suggest a simple diagnostic algorithm can be used to rule out PE in a significant number of these patients, eliminating their need for CTPA.

Subscribe to RSS - pulmonary embolism